News Release | Investor Relations | Corporate Information

FY2025

October 31, 2025	Summary of Consolidated Financial Results for the Second Quarter of FY2025. (pdf, 187KB)
October 31, 2025	Second quarter business summary FY2025. (pdf, 664KB)
August 29, 2025	Corporate Report 2025 (Annual Report FY2024) (pdf, 1.2MB)
July 31, 2025	Summary of Consolidated Financial Results for the First Quarter of FY2025. (pdf, 175KB)
July 31, 2025	First quarter business summary FY2025. (pdf, 549KB)
June 5, 2025	Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income) (pdf, 149KB)
May 27, 2025	Notice of the 93rd Ordinary General Meeting of Shareholders. (pdf, 708KB)
May 14, 2025	Summary of Consolidated Financial Results for the Fiscal Year 2024. (pdf, 257KB)
May 14, 2025	Business summary FY2024. (pdf, 1,200KB)
April 21, 2025	Discovery that citrate, which keeps the body's internal environment weakly alkaline, is effective in preventing or treating peripheral neuropathy induced by anticancer drugs. (pdf, 445KB)